Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma.
Elizabeth GeorgeElizabeth FlaggKen ChangHarrison X BaiHugo J W L AertsMartin VallièresDavid A ReardonRaymond Y HuangPublished in: AJNR. American journal of neuroradiology (2022)
A radiomics-based machine learning model from first on-treatment MR imaging predicts survival in patients with glioblastoma on programmed death-ligand 1 inhibition immunotherapy.
Keyphrases